May 27, 2021 7:30am EDT ProMIS Neurosciences appoints renowned scientist, Dr. David Wishart as Chief Physics Officer
May 21, 2021 8:30am EDT ProMIS Neurosciences re-initiates path to IND for PMN310 with producer cell line development
May 19, 2021 6:30am EDT ProMIS Neurosciences appoints accomplished biotechnology executive, Neil Warma, to its Board of Directors
May 12, 2021 6:30am EDT ProMIS Neurosciences appoints renowned neuroscientist, Dr. Rudolph Tanzi, as Chair of Scientific Advisory Board
Mar 22, 2021 10:44am EDT ProMIS Neurosciences Completes US$7M (CDN$8.75M) Financing with Distinguished Group of Boston Based Investors
Feb 02, 2021 8:30am EST ProMIS Neurosciences Offers Perspectives on Recent Progress in the Alzheimer’s/Amyloid Field